In addition, IHC results from a large group of RCC samples further supported the idea that METTL14 expression is positively associated with BPTF, ENO2, and SRC, suggesting the robustness of the METTL14/BPTF axis in enhancing RCC glycolysis. Here, METTL14 is linked to renal cell carcinoma.